Biocompatibility: Documenting all the Risks (Online)
RECORDING WILL BE AVAILABLE TO MDG BOSTON MEMBERS AFTER THE EVENT
SPONSORSHIP OPPORTUNITY (Registration Below)
$200 Sponsorship: Includes a complimentary ticket for a guest (= 2 total free registrations), approximately 2 minute of microphone time for introductions, and branding on MDG Boston’s promotional materials (assuming a sponsor is signed up prior to MDG Boston’s distribution of promotional materials).
When & Where
Date: Wed Oct 28, 2026
Time: 12:00 – 1:30 PM
Location: Online
Abstract
Join Paolo Pescio, MBA, ERT, Global Director Biocompatibility & Toxicology at Fresenius Medical Care and Geoffrey Moodie, Ph.D. Principal Biocompatibility Engineer, Group Leader at ZOLL for an in-depth discussion on biocompatibility and what the latest regulatory changes mean for you.
Paolo is a technical expert on the ISO committee that developed the new ISO 10993-1:2025 standard and is currently contributing to the development of the forthcoming ISO guidance document on the application of this standard throughout the medical device lifecycle, so you will have opportunity to hear the most current thinking.
Geoff has over 20 years of experience in medical device safety and efficacy testing and is on multiple AAMI committees providing US industry feedback to multiple standards.
Biological risk assessment is not just a checkbox: it’s a critical risk assessment that needs to be treated as such, exploring potential risks from raw materials to manufacturing processes to final packaging and aging, Regulatory agencies are already asking tough questions that go well beyond rote test results. Are you ready to meet this modern expectation?
If you have open questions this is your opportunity to talk to two seasoned experts actively engaged in the field. You’ll gain practical insights into implementing strategies that satisfy regulators while ensuring patient safety. Whether you’re in R&D, regulatory affairs, or quality assurance, this discussion will help you stay ahead of evolving expectations and avoid costly delays or compliance issues.
✅ Reserve your spot today and equip your team with the knowledge to navigate the new regulatory landscape with confidence.
Tickets
– MDG Boston Members: $25
– Non-Members: $50 (Can be applied to a $95 Professional Membership – Click HERE and use this discount code: 50Discount at checkout)
– MDG Boston Staff & Sponsors – No Charge [PLEASE DO NOT USE THIS TICKET UNLESS YOU ARE IN THESE CATEGORIES]
REGISTER HERE, UNLESS SELECTING THE $95 PROFESSIONAL MEMBERSHIP DISCOUNT OPTION
Panelists
MODERATOR
Geoff Moodie, PhD
Principal Biocompatibility Engineer at Zoll Medical
Geoff Moodie has over 20 years of experience in medical device safety and efficacy testing across a wide variety of products, from dental products to drug eluting stents, including erodible coatings, and new chemical entities. Since his tissue engineering graduate work he has been focused on the interaction between host tissue and medical devices, which explains his career focus on biocompatibility. He is an AAMI committee member participating in reviewing proposed ISO biocompatibility standards.
Paolo Pescio, MBA, ERT
Director, Global Biocompatibility and Toxicology Competence Center, Fresenius Medical Care